DB
BIO icon

Danske Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Danske Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.87K Hold
20
– – ﹤0.01% 901
2026
Q1 		$5.58K Sell
20
-80
-80% -$23K ﹤0.01% 897
2025
Q4 		$30.3K Buy
+100
New +$31.2K ﹤0.01% 1114
2025
Q2 		– Sell
-5,283
Closed -$1.29M – 1533
2025
Q1 		$1.29M Sell
5,283
-1,200
-19% -$361K ﹤0.01% 789
2024
Q4 		$2.13M Buy
6,483
+1,100
+20% +$373K 0.01% 638
2024
Q3 		$1.8M Buy
5,383
+100
+2% +$31.8K 0.01% 675
2024
Q2 		$1.44M Sell
5,283
-2,206
-29% -$642K 0.01% 680
2024
Q1 		$2.59M Buy
+7,489
New +$2.46M 0.01% 648

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Danske Bank's BIO Position: Q2 2026 in Review

Danske Bank held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 20 shares worth $5.87K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Danske Bank first reported a position in BIO in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.59M in Q1 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Danske Bank held 20 shares of Bio-Rad Laboratories Class A worth $5.87K as of Q2 2026.
  • Danske Bank left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #901 holding.
  • Danske Bank first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and has held it in 8 quarters since.
  • Danske Bank's Bio-Rad Laboratories Class A position peaked at $2.59M in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.